{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:51:37Z","timestamp":1790783497996,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008211","name":"Drexel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015696","name":"Siemens Medical Solutions USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.actbio.2021.05.046","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T12:20:52Z","timestamp":1622463652000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Gemcitabine-loaded microbubble system for ultrasound imaging and therapy"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6794-9550","authenticated-orcid":false,"given":"Lauren J.","family":"Delaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Eisenbrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0783-1723","authenticated-orcid":false,"given":"Maria","family":"Stanczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-1371","authenticated-orcid":false,"given":"Flemming","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-9162","authenticated-orcid":false,"given":"Ji-Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2021.05.046_bib0001","unstructured":"American Cancer Society, Key statistics for pancreatic cancer, 2019. http:\/\/www.cancer.org\/cancer\/pancreaticcancer\/detailedguide\/pancreatic-cancer-key-statistics. Accessed July 2019)."},{"issue":"2","key":"10.1016\/j.actbio.2021.05.046_bib0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0301-5629(91)90125-G","article-title":"Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound","volume":"17","author":"Apfel","year":"1991","journal-title":"Ultrasound Med. Biol."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.046_bib0003","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.actbio.2021.05.046_bib0004","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.046_bib0005","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0006","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.046_bib0007","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SLA.0b013e3180691579","article-title":"National failure to operate on early stage pancreatic cancer","volume":"246","author":"Bilimoria","year":"2007","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.actbio.2021.05.046_bib0008","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejso.2007.01.022","article-title":"Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies","volume":"33","author":"Kleeff","year":"2007","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.046_bib0009","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer","volume":"297","author":"Oettle","year":"2007","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bjc.1996.18","article-title":"Phase II study of gemcitabine in patients with advanced pancreatic cancer","volume":"73","author":"Carmichael","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.actbio.2021.05.046_bib0011","first-page":"116","article-title":"Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis","volume":"23","author":"Ergun","year":"2018","journal-title":"J. Balkan Union Oncol."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pan.2018.10.003","article-title":"Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe","volume":"19","author":"Javed","year":"2019","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0013","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0014","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","article-title":"Pancreatic cancer: from state-of-the-art treatments to promising novel therapies","volume":"12","author":"Garrido-Laguna","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.actbio.2021.05.046_bib0015","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: a changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"issue":"5933","key":"10.1016\/j.actbio.2021.05.046_bib0016","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccr.2014.05.026","article-title":"Pancreatic cancer stroma: friend or foe?","volume":"25","author":"Gore","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0018","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0019","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0020","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/0008-5472.CAN-07-6102","article-title":"Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent","volume":"68","author":"Patra","year":"2008","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.actbio.2021.05.046_bib0021","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.18632\/oncotarget.7931","article-title":"Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine","volume":"7","author":"Quinn","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.actbio.2021.05.046_bib0022","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/nat.2012.0353","article-title":"Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells","volume":"22","author":"Ray","year":"2012","journal-title":"Nucl. Acid Ther."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0023","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mt.2016.60","article-title":"Targeted delivery of C\/EBP\u03b1-saRNA by pancreatic ductal adenocarcinoma-specific RNA aptamers inhibits tumor growth in vivo","volume":"24","author":"Yoon","year":"2016","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0024","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2014.04.021","article-title":"Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: A comparison with its self-assembled nanoparticles","volume":"468","author":"Daman","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2011.08.004","article-title":"Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1","volume":"157","author":"Chung","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.actbio.2021.05.046_bib0026","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2004.09.001","article-title":"Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs","volume":"100","author":"Immordino","year":"2004","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.actbio.2021.05.046_bib0027","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/aps.2009.125","article-title":"Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro","volume":"30","author":"Li","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"1-2","key":"10.1016\/j.actbio.2021.05.046_bib0028","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2014.11.009","article-title":"Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies","volume":"482","author":"Maksimenko","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.actbio.2021.05.046_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2007.06.006","article-title":"Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules","volume":"344","author":"Stella","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2021.05.046_bib0030","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.2147\/IJN.S93835","article-title":"An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line","volume":"10","author":"Yu","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.actbio.2021.05.046_bib0031","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.nano.2011.03.009","article-title":"Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy","volume":"7","author":"Arya","year":"2011","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.actbio.2021.05.046_bib0032","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1021\/acs.biomac.8b00959","article-title":"Self-healing pH-and enzyme stimuli-responsive hydrogels for targeted delivery of gemcitabine to treat pancreatic cancer","volume":"19","author":"Bilalis","year":"2018","journal-title":"Biomacromolecules"},{"issue":"11","key":"10.1016\/j.actbio.2021.05.046_bib0033","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nature materials"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0034","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbcan.2009.10.001","article-title":"Targeted drug delivery in pancreatic cancer","volume":"1805","author":"Yu","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"issue":"9","key":"10.1016\/j.actbio.2021.05.046_bib0035","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.molpharmaceut.9b00416","article-title":"Enhancing Nab-paclitaxel delivery using microbubble-assisted ultrasound in a pancreatic cancer model","volume":"16","author":"Bressand","year":"2019","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0036","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2018.01.042","article-title":"Sensitization of hypoxic tumors to radiation therapy using ultrasound-sensitive oxygen microbubbles","volume":"101","author":"Eisenbrey","year":"2018","journal-title":"Int. J. Radiat. Oncol.* Biol.* Phys."},{"issue":"23","key":"10.1016\/j.actbio.2021.05.046_bib0037","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1002\/smll.201300161","article-title":"Targeted liposome-loaded microbubbles for cell-specific ultrasound-triggered drug delivery","volume":"9","author":"Geers","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.actbio.2021.05.046_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.12.032","article-title":"Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts","volume":"391","author":"Luo","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2021.05.046_bib0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2013.12.010","article-title":"State-of-the-art materials for ultrasound-triggered drug delivery","volume":"72","author":"Sirsi","year":"2014","journal-title":"Adv. Drug Del. Rev."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.046_bib0040","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.ultrasmedbio.2017.06.029","article-title":"Ultrasound improves the delivery and therapeutic effect of nanoparticle-stabilized microbubbles in breast cancer xenografts","volume":"43","author":"Snipstad","year":"2017","journal-title":"Ultrasound Med. Biol."},{"issue":"9","key":"10.1016\/j.actbio.2021.05.046_bib0041","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1021\/mp500835z","article-title":"Targeted microbubbles for ultrasound mediated short hairpin RNA plasmid transfection to inhibit survivin gene expression and induce apoptosis of ovarian cancer A2780\/DDP cells","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2021.05.046_bib0042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"},{"issue":"1-2","key":"10.1016\/j.actbio.2021.05.046_bib0043","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2011.05.030","article-title":"Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery","volume":"414","author":"Cochran","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.actbio.2021.05.046_bib0044","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.acra.2011.06.013","article-title":"Disposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Model","volume":"18","author":"Cochran","year":"2011","journal-title":"Acad. Radiol."},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2009.12.021","article-title":"Development and optimization of a doxorubicin loaded poly (lactic acid) contrast agent for ultrasound directed drug delivery","volume":"143","author":"Eisenbrey","year":"2010","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.actbio.2021.05.046_bib0046","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ultras.2009.03.003","article-title":"Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents","volume":"49","author":"Eisenbrey","year":"2009","journal-title":"Ultrasonics"},{"key":"10.1016\/j.actbio.2021.05.046_bib0047","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biomaterials.2016.06.036","article-title":"Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential","volume":"103","author":"Jablonowski","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0048","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamem.2006.01.009","article-title":"Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations","volume":"1758","author":"Johnston","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.actbio.2021.05.046_bib0049","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.ultrasmedbio.2011.08.004","article-title":"Cavitation-enhanced extravasation for drug delivery","volume":"37","author":"Arvanitis","year":"2011","journal-title":"Ultrasound Med. Biol."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.046_bib0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2012.08.014","article-title":"Crucial factors and emerging concepts in ultrasound-triggered drug delivery","volume":"164","author":"Geers","year":"2012","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.actbio.2021.05.046_bib0051","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbm.a.10586","article-title":"Development of a novel method for synthesis of a polymeric ultrasound contrast agent","volume":"66","author":"El-Sherif","year":"2003","journal-title":"J. Biomed. Mater. Res. Part A"},{"issue":"9","key":"10.1016\/j.actbio.2021.05.046_bib0052","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.actbio.2021.05.046_bib0053","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/dmd.119.089334","article-title":"Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines","volume":"48","author":"Bj\u00e5nes","year":"2020","journal-title":"Drug Metab. Disposition"},{"issue":"10","key":"10.1016\/j.actbio.2021.05.046_bib0054","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.actbio.2021.05.046_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-5173(97)00154-3","article-title":"Drug release from PLA\/PEG microparticulates","volume":"156","author":"Huang","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.actbio.2021.05.046_bib0056","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ultras.2006.04.003","article-title":"Comparison of in vitro and in vivo acoustic response of a novel 50: 50 PLGA contrast agent","volume":"44","author":"Wheatley","year":"2006","journal-title":"Ultrasonics"},{"key":"10.1016\/j.actbio.2021.05.046_bib0057","article-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"1996","journal-title":"Curr. Biol. Lond."},{"issue":"27","key":"10.1016\/j.actbio.2021.05.046_bib0058","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1016\/j.biomaterials.2011.05.027","article-title":"The role of poly (ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"issue":"7058","key":"10.1016\/j.actbio.2021.05.046_bib0059","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","article-title":"Structures of complement component C3 provide insights into the function and evolution of immunity","volume":"437","author":"Janssen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2021.05.046_bib0060","first-page":"557","article-title":"Investigation of endocytosis and cytotoxicity of poly-d, l-lactide-poly (ethylene glycol) micro\/nano-particles in osteoblast cells","volume":"5","author":"Wang","year":"2010","journal-title":"Int. J. Nanomed."},{"issue":"43","key":"10.1016\/j.actbio.2021.05.046_bib0061","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1021\/acs.langmuir.5b03473","article-title":"Nanoparticle Loaded Polymeric Microbubbles as Contrast Agents for Multimodal Imaging","volume":"31","author":"Teraphongphom","year":"2015","journal-title":"Langmuir"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121003561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121003561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:46:44Z","timestamp":1761673604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121003561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":61,"alternative-id":["S1742706121003561"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.05.046","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemcitabine-loaded microbubble system for ultrasound imaging and therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}